Fewer Investors Than Expected Jumping On Cytek Biosciences, Inc. (NASDAQ:CTKB)
Express News | Cytek Biosciences Inc : TD Cowen Cuts Target Price to $9 From $12
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Intrinsic Value Is Potentially 99% Above Its Share Price
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?
Express News | Cytek Biosciences Inc - to Not Replace COO Position, Opting to Restructure Organization
Cytek Biosciences: Williams to Accept CEO Position at Another Company >CTKB
Press Release: Cytek Announces Resignation of Chief Operating Officer Chris Williams
Express News | Cytek Biosciences Shares Are Trading Lower After COO Paul Christopher Williams Submitted His Resignation, Effective Sept. 27
Cytek Biosciences COO Resigns, Signaling Leadership Changes
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8
Express News | Cytek Says Its San Diego Reagent Manufacturing Facility Secured EN ISO 13485:2016 Quality Management System Certification
Express News | Cytek® Biosciences Achieves Iso 13485 Certification at San Diego Reagent Manufacturing Facility
Express News | Cytek Biosciences Inc : Stephens Cuts Target Price to $7.5 From $10
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8
Express News | Piper Sandler Maintains Overweight on Cytek Biosciences, Lowers Price Target to $8
Cytek Biosciences Analyst Ratings
Express News | Cytek Biosciences Inc : Piper Sandler Cuts Target Price to $8 From $8.5
Cytek Biosciences: Hold Rating Amidst Mixed Performance and Cautious U.S. Market Outlook
Earnings Call Summary | Cytek Biosciences(CTKB.US) Q2 2024 Earnings Conference
Institutional Owners May Take Dramatic Actions as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent 15% Drop Adds to One-year Losses